Clinical Electives July June % Response Rate

Transcription

1 July 1 - June 11 1% Response Rate Pediatric Hematology-Oncology Consultation OP Elective Effort How many credit weeks was this elective?... - Weeks 4-4 Weeks 6-6 Weeks 8-8 Weeks Weeks Total Approximately how many hours/week did you spend in formal teaching sessions/didactics including lectures, small group discussions, grand rounds etc.? 1- hours per week -1-3 hours per week hours per week hours per week hours per week hours per week 7-> hours per week 4-6 hours per week Total The amount of didactics/formal teaching in this elective was Probably not enough, could be a bit more Probably not enough, could be a bit more The perfect amount Total The overall workload for this elective was Probably not enough, could be a bit more Probably not enough, could be a bit more The perfect amount Total 1. 1.

2 July 1 - June 11 1% Response Rate Pediatric Hematology-Oncology Consultation OP Please indicate the extent to which you agree or disagree with the following statements. This elective was well organized No Opinion -Mostly Disagree Mixed Feelings Mostly Agree Total This elective had clear goals and objectives No Opinion -Mostly Disagree Mostly Disagree Mixed Feelings Total Please assess the adequacy of the following aspects of this clinical elective: Approximately how many hours/week did you spend working directly with patients (e.g., history taking, physical exam, and assessment and planning) or discussing patients with the medical team? hours per week -1-3 hours per week hours per week hours per week hours per week hours per week 7-> hours per week > hours per week Total The number of patients you saw was Probably not enough, could be a bit more Probably not enough, could be a bit more Total 1. 1.

3 July 1 - June 11 1% Response Rate Pediatric Hematology-Oncology Consultation OP Please assess the adequacy of the following aspects of this clinical elective: The variety of patients (mix/pathology) you saw was... -Probably not enough, could be a bit more The perfect amount Total The amount of responsibility you were given was Probably not enough, could be a bit more Probably not enough, could be a bit more The perfect amount Total The amount of clinical supervision you received was... -Probably not enough, could be a bit more The perfect amount Total How effective was this elective at providing you the experiences you needed to... gain a significant amount of knowledge on the topic of this elective? -No Opinion -Somewhat Effective Very Effective Total 1. 1.

4 July 1 - June 11 1% Response Rate Pediatric Hematology-Oncology Consultation OP How effective was this elective at providing you the experiences you needed to... achieve a respectable level of skills related to the topic of this elective? No Opinion -Somewhat Effective Mixed Feelings Very Effective Total gain exposure to pertinent literature and research in the field covered in the elective? -No Opinion -Somewhat Effective Very Effective Total Overall Overall, I am satisfied with the quality of the learning experience I received from this elective. -No Opinion -Mostly Disagree Mostly Agree Total How strongly would you recommend this elective to other students? 1-Not recommend at all -Probably not recommend 3-Might recommend 4-Probably recommend 5-Definitely recommend Might recommend Definitely recommend Total 1. 1.

5 July 1 - June 11 1% Response Rate Comments for Pediatric Hematology-Oncology Consultation OP or 3 Strengths of this elective? excellent mix of inpatient, outpatient and procedures. Would be a great 4 week elective, a lot to see in just weeks! Comments for Pediatric Hematology-Oncology Consultation OP or 3 Areas Needing Improvement? I was sent several articles by Dr. Raj that were very nice to have in order to read before going to a given clinic or to read in between patients. It would be nice to provide several reliable review articles to students upon starting this elective. Perhaps one each for late effects, AML, ALL, Hodgkin's disease, bone tumors, wilm's, neuroblastoma, neuroonc, bleeding disorders, and sickle cell disease.